atorvastatin has been researched along with folic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Park, A | 1 |
| Boroumand, MA; Djalali, M; Eshragian, MR; Khatami, MR; Shojaei, MH; Siassi, F | 1 |
| Huang, J; Li, HH; Liang, FL; Mo, JL; Ou, BQ; Peng, Y; Zhou, Z | 1 |
| Fang, F; Fang, Z; Li, J; Li, X; Li, Y; Wang, J; Wang, X | 1 |
| Al Kotob, A; Al Osta, S; Atwi, G; Chamoun, N; Ghanem, G; Jamal, O; Jamaleddine, W; Matli, K; Mokhbat, J; Moussawi, A; Saad, JM; Saad, TA; Salameh, P; Tabbikha, R | 1 |
1 review(s) available for atorvastatin and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atorvastatin and folic acid
| Article | Year |
|---|---|
Managing endothelial dysfunction in COVID-19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double-blind, placebo-controlled, randomized clinical trial.
Topics: Arginine; Atorvastatin; COVID-19 Drug Treatment; Double-Blind Method; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Nebivolol; Nicorandil; SARS-CoV-2; Treatment Outcome | 2022 |
5 other study(ies) available for atorvastatin and folic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The state of the heart. If you thought cholesterol was all you had to worry about, better think again.
Topics: American Heart Association; Anticholesteremic Agents; Atorvastatin; Cholesterol; Coronary Disease; Folic Acid; Heptanoic Acids; Humans; Inflammation; Pyrroles; United States | 2000 |
Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cardiovascular Diseases; Cross-Sectional Studies; Eating; Female; Folic Acid; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipoprotein(a); Lovastatin; Male; Middle Aged; Pyrroles; Renal Dialysis; Risk Factors; Vitamin B 6; Vitamin B Complex; Young Adult | 2009 |
Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia.
Topics: Aged; Aged, 80 and over; Atorvastatin; China; Chronic Disease; Female; Folic Acid; Heart Failure; Heart Function Tests; Humans; Hyperhomocysteinemia; Male; Middle Aged; Ventricular Remodeling | 2018 |
Evaluation of the Effects of Folic Acid Combined with Atorvastatin on the Poststroke Cognitive Impairment by Low-Rank Matrix Denoising Algorithm-Based MRI Imaging.
Topics: Algorithms; Atorvastatin; Cognitive Dysfunction; Folic Acid; Humans; Ischemic Stroke; Magnetic Resonance Imaging; Stroke | 2022 |